Home›Companies›Healthcare›Cellens

Cellens, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 14, 2025·Suggest an edit

About Cellens

Cellens is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $7,025,526 raised in two offerings on Form D since October 2022. Its chief executive is Phuong (Jean) Pham.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 14, 2025Nov 14, 2025$6,440,526fully sold33$195KEquityRule 506(b)Form D ↗
Apr 20, 2022Oct 14, 2022$585,000of $1.5M target15$39,000DebtRule 506(b)Form D ↗
Total, two offerings$7,025,526

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cellens's Form D filed Nov 14, 2025.

DZ
MI
Mohan Iyer
Director
JS
Jesse Salk
Director
Also a director at CytoTerra and a chief executive officer and director at TwinStrand Biosciences.
PP
Phuong (Jean) Pham
CEO and director

Sources

  1. SECCellens, Inc. filing history